Nov. 18, 2015
  1. AskMayoExpert. Pemphigus. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
  2. Pemphigus. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Accessed Sept. 3, 2015.
  3. Martin LK, et al. Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database of Systematic Reviews. Accessed Sept. 3, 2015.
  4. Bope ET, et al. Diseases of the skin. In: Conn's Current Therapy 2015. Philadelphia, Pa.: Saunders Elsevier; 2015. Accessed Sept. 3, 2015.
  5. Kasperkiewicz M, et al. Current therapy of the pemphigus group. Clinics in Dermatology. 2012;30:84.
  6. Venugopal SS, et al. Diagnosis and clinical features of pemphigus vulgaris. Dermatology Clinics. 2011;29:373.
  7. Heelan K, et al. Durable remission of pemphigus with a fixed-dose rituximab protocol. JAMA Dermatology. 2014;150:703.
  8. Patterson JW. The vesiculobullous reaction pattern. In: Weedon's Skin Pathology. 4th ed. Maryland Heights, Mo.: Churchill Livingstone Elsevier; 2016.
  9. Goldsmith LA, et al., eds. Pemphigus. In: Fitzpatrick's Dermatology in General Medicine. 8th ed. New York, N.Y.: The McGraw-Hill Companies; 2012. Accessed Sept. 9, 2015.
  10. Hertl M, et al. Management of refractory pemphigus vulgaris and pemphigus foliaceus. Accessed Sept. 3, 2015.
  11. Hertl M, et al. Initial management of pemphigus vulgaris and pemphigus foliaceus. Accessed Sept. 3, 2015.
  12. Saag KG, et al. Major side effects of systemic glucocorticoids. Accessed Sept. 8, 2015.
  13. Ferri FF. Managing pemphigus vulgaris. In: Ferri's Clinical Advisor 2016. Philadelphia, Pa.: Mosby Elsevier; 2016.
  14. Pemphigus vulgaris. Merck Manuals Professional Edition. Accessed Sept. 9, 2015.
  15. Mustafa MB, et al. Oral mucosal manifestations of autoimmune skin diseases. Autoimmunity Reviews. 2015;14:930.
  16. Gibson LE (expert opinion). Mayo Clinic, Rochester, Minn. Oct. 13, 2015.